CD80 and colonic neoplasm: Our findings shed new light onto the complex regulation in colon epithelial cells of the costimulatory molecule CD80, that proved to be an important mediator of immune defense against colon cancer development, and might provide the basis for novel strategies that exploit anti-tumor immunity to prevent and/or control colon cancer.